Literature DB >> 17349209

Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.

Ruaidhrí J Carmody1, Youhai H Chen.   

Abstract

Toll-like receptors (TLRs) recognize distinct microbial components to initiate the innate and adaptive immune responses. TLR activation culminates in the expression of appropriate pro-inflammatory and immunomodulatory factors to meet pathogenic challenges. The transcription factor NF-kappaB is the master regulator of all TLR-induced responses and its activation is the pivotal event in TLR-mediated activation of the innate immune response. Many of the key molecular events required for TLR-induced NF-kappaB activation have been elucidated. However, much remains to be learned about the ability of TLRs to generate pathogen-specific responses using a limited number of transcription factors. This review will focus on our current understanding of NF-kappaB activation by TLRs and potential mechanisms for achieving a signal-specific response through NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349209

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  73 in total

1.  Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling.

Authors:  Shu-Chen Wei; Ian M Rosenberg; Zhifang Cao; Alan S Huett; Ramnik J Xavier; Daniel K Podolsky
Journal:  Inflamm Bowel Dis       Date:  2012-01-23       Impact factor: 5.325

2.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.

Authors:  Eleni Arvaniti; Stavroula Ntoufa; Nikos Papakonstantinou; Tasoula Touloumenidou; Nikolaos Laoutaris; Achilles Anagnostopoulos; Klea Lamnissou; Federico Caligaris-Cappio; Kostas Stamatopoulos; Paolo Ghia; Marta Muzio; Chrysoula Belessi
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

3.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Authors:  Theodore Mazzone
Journal:  Circulation       Date:  2010-11-23       Impact factor: 29.690

Review 4.  Regulation of airway mucin gene expression.

Authors:  Philip Thai; Artem Loukoianov; Shinichiro Wachi; Reen Wu
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

5.  NETWORKS, BIOLOGY AND SYSTEMS ENGINEERING: A CASE STUDY IN INFLAMMATION.

Authors:  P T Foteinou; E Yang; I P Androulakis
Journal:  Comput Chem Eng       Date:  2009-12-10       Impact factor: 3.845

6.  A synergistic role for IL-1beta and TNFalpha in monocyte-derived IFNgamma inducing activity.

Authors:  Raquel M Raices; Yashaswini Kannan; Anasuya Sarkar; Vedavathi Bellamkonda-Athmaram; Mark D Wewers
Journal:  Cytokine       Date:  2008-09-19       Impact factor: 3.861

7.  Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.

Authors:  Patricia E Collins; Patrick A Kiely; Ruaidhrí J Carmody
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

8.  The IκB family member Bcl-3 coordinates the pulmonary defense against Klebsiella pneumoniae infection.

Authors:  Frédéric Pène; Andrea Paun; Søren Ulrik Sønder; Nimisha Rikhi; Hongshan Wang; Estefania Claudio; Ulrich Siebenlist
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

9.  Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia.

Authors:  Hongquan Dong; Wei Zhang; Xiaoning Zeng; Gang Hu; Huiwen Zhang; Shaoheng He; Shu Zhang
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

10.  Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1.

Authors:  Marcus Mühlbauer; Adam W Cheely; Suresh Yenugu; Christian Jobin
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.